Clinical Trial Update: Thalidomide fOr the Prevention of Restenosis After Coronary ArtERy Stent Implantation [Phase 4]

View source ↗

Summary

Update on a Phase 4 trial evaluating thalidomide to prevent restenosis after coronary artery stent implantation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Thalidomide (thalidomide)

Snippet

Sponsor: University of Roma La Sapienza | Conditions: Coronary Artery Disease | Phase 4 | Status: UNKNOWN